Organ-Based Toxicities
NEW! Launching in Fall 2025
Leadership
Vice-Chair
TBD
Organ-Based Toxicities is a subgroup of the Emerging Toxicities Study Group
Mission and Goals
Emerging anticancer agents often have narrow therapeutic windows and can cause significant organ damage. The Organ-Based Toxicities Subgroup will focus on the development of research studies, guidelines, and educational initiatives to enhance patient safety and longer term outcomes for the use of these emerging agents, with the aim of providing leadership in continual improvement of supportive care and treatment outcomes.
Cardiac and kidney toxicities will be particular focuses.
How to Join
To join a subgroup, you must be a MASCC member and a member of the parent study group. The parent study group of the Organ-Based Toxicities Subgroup is the Lifestyle & Integrative Medicine Study Group.